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DREAM (downstream regulatory element antagonist modulator) also known as calsenilin or KChIP-3
is a calcium binding protein that has been associated with memory retention, pain sensing, calcium
homeostasis  and  Alzheimer’s  disease.  It  has  two  EF  hands  that  bind  Ca2+  and  change  the
conformation of the protein. DREAM has two hydrophobic cavities in both the N- and C- terminus.
These hydrophobic sites act as important binding sites with Kv channels, presenilin and other small
molecules. Previously our group has showed that hydrophobic molecules such as NS5806 and 1,8-
ANS can bind to the hydrophobic cavities in the C-terminus. The aim of this investigation was to
characterize interactions of other hydrophobic molecules with DREAM with a long-term goal of
finding a potential inhibitor for DREAM interacting with presenilin. In silico and in vitro approaches
were used to determine a mechanism of binding of DREAM with hydrophobic molecules NS5806,
NS3623,  bezafibrate,  trifluoperazine,  5-biphenyl-2-yl-1H-tetrazole,  N-[(4-phenylphenyl)methyl]-
2H-tetrazol-5-amine and cholesterol. Three binding sites were identified at the C-terminus and N-
terminus. The most favored binding site was in the C-terminus in the hydrophobic pocket of the EF-
4. All the hydrophobic molecules tested showed strong binding in this region. The major contributing
residues were HIS 214, TYR 174, MET 187 and PHE 218. Other binding sites found resided in the
hydrophobic pocket in the N-terminus but binding was shown to be weaker with many unfavorable
residue interactions. Additional binding site was identified in between EF-3 and EF-4 but had many
unfavorable interactions. An inhibitor with a high affinity for DREAM binding to presenilin would be
beneficial in the blocking of gamma secretase complex which may lead to a better understanding of
the physiology and treatment of Alzheimer disease.
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